Compare Cassava Sciences Inc (FLNA) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Warner Music Group Corp — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Warner Music Group Corp trades at $28.72 (market cap $15.12B). The key difference: Warner Music Group Corp is far larger — about 383.8× Cassava Sciences Inc's market cap, and Warner Music Group Corp pays a 2.77% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Warner Music Group Corp for 96 Days on average.
| FLNA | WMG | |
|---|---|---|
Market Cap | $39.40M | $15.12B |
Volume | 759,018 | 2,966,414 |
Sector | Health | Media |
52-Week High | $4.64 | $34.72 |
52-Week Low | $0.68 | $23.65 |
Typical Hold Time | 37 Days | 96 Days |
Enterprise Value | -$43.28M | $19.42B |
Dividend Yield | — | 2.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8136, down 0.26% today, with a bearish technical signal from moving averages but neutral oscillators. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates in recent quarters. Recent positive news includes FDA lifting a clinical hold on its epilepsy drug, enabling Phase 2a studies.
The outlook remains high-risk due to persistent negative cash flows and lack of revenue, but analyst consensus is bullish with 67% buy ratings. Key risks include clinical trial execution and funding needs, while the FDA decision provides a potential catalyst for long-term investors focused on biotech turnaround stories.
Warner Music Group (WMG) trades at $28.72, up 1.99% today, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating EPS estimates, and maintains a robust gross profit margin of 45.77%. Recent news highlights strategic AI partnerships and licensing renewals, signaling growth initiatives. Revenue has grown from $5.9B in 2022 to $6.7B in 2025, with a projected increase to $7.3B in 2026.
The outlook for WMG is positive, driven by earnings beats, analyst optimism, and AI-driven content curation opportunities. Key risks include competitive pressures in the music industry and execution challenges amid leadership changes. The consensus price target of $39.50 implies significant upside, but investors should monitor margin trends and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
